ICM
HBI

Invenomic Capital Management’s Hanesbrands HBI Stock Holding History

Invenomic Capital Management’s Portfolio HBI Stock Details HBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,750,911
Closed -$14.5M – 144
2023
Q1 		$14.5M Sell
2,750,911
-950,057
-26% -$5.98M 0.82% 41
2022
Q4 		$23.5M Buy
3,700,968
+1,269,850
+52% +$8.72M 1.6% 17
2022
Q3 		$16.9M Buy
2,431,118
+1,749,471
+257% +$17.2M 1.45% 22
2022
Q2 		$7.01M Buy
681,647
+390,430
+134% +$4.85M 0.5% 63
2022
Q1 		$3.5M Buy
291,217
+222,413
+323% +$3.5M 0.37% 75
2021
Q4 		$1.15M Buy
+68,804
New +$1.17M 0.25% 106

Other funds holding HBI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Invenomic Capital Management's HBI Position: Q2 2023 in Review

Invenomic Capital Management sold out of Hanesbrands (HBI) in Q2 2023, closing a stake of 2,750,911 shares — an estimated $14.5M sold.

Invenomic Capital Management first reported a position in HBI in Q4 2021 and held it in 6 quarters. The position peaked at $23.5M in Q4 2022. 450 funds tracked by Wall St. Rank hold HBI as of Q2 2023.

  • Invenomic Capital Management reported no remaining Hanesbrands position as of Q2 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 2,750,911 Hanesbrands shares in Q2 2023, an estimated $14.5M.
  • Invenomic Capital Management first reported a position in Hanesbrands in Q4 2021 and held it in 6 quarters.
  • Invenomic Capital Management's Hanesbrands position peaked at $23.5M in Q4 2022.
  • 450 funds tracked by Wall St. Rank held Hanesbrands as of Q2 2023.

Based on Invenomic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.